Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$1.61B |
| 2 |
ExxonMobil
XOM
|
+$1.58B |
| 3 |
Coca-Cola
KO
|
+$1.05B |
| 4 |
Occidental Petroleum
OXY
|
+$979M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$956M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$2.73B |
| 2 |
Salesforce
CRM
|
+$2.07B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Altria Group
MO
|
+$1.41B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.63% |
| 2 | Healthcare | 15.44% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Aclaris Therapeutics
ACRS
$869M
| $17.3M | ﹤0.01% |
1,242,308
+28,958
| +2% | +$406K |
|
|
CWEN.A
1677
DELISTED
Clearway Energy Class A
CWEN.A
| $17.3M | ﹤0.01% |
542,029
+162,438
| +43% | +$5.06M |
|
1678
ABM Industries
ABM
$2.84B
| $17.3M | ﹤0.01% |
398,426
+255,471
| +179% | +$11.8M |
|
1679
Oil States International
OIS
$491M
| $17.3M | ﹤0.01% |
3,189,869
-46
| -0% | -$321 |
|
|
SOND
1680
DELISTED
Sonder
SOND
| $17.2M | ﹤0.01% |
854,258
-43,036
| -5% | -$2.45M |
|
|
NSA
1681
DELISTED
National Storage Affiliates Trust
NSA
| $17.1M | ﹤0.01% |
342,240
-153,042
| -31% | -$8.33M |
|
|
BHVN
1682
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $17.1M | ﹤0.01% |
117,508
-1,434,343
| -92% | -$183M |
|
1683
Penske Automotive Group
PAG
$14.2B
| $17.1M | ﹤0.01% |
163,319
+10,701
| +7% | +$1.15M |
|
1684
Regional Management Corp
RM
$303M
| $17.1M | ﹤0.01% |
457,478
+59
| +0% | +$2.61K |
|
|
LTHM
1685
DELISTED
Livent Corporation
LTHM
| $17M | ﹤0.01% |
749,853
+52,626
| +8% | +$1.35M |
|
|
RBCP
1686
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $16.9M | ﹤0.01% |
177,600
+33,700
| +23% | +$3.13M |
|
1687
MakeMyTrip
MMYT
$5.64B
| $16.9M | ﹤0.01% |
658,007
-291,513
| -31% | -$7.53M |
|
|
RVNC
1688
DELISTED
Revance Therapeutics, Inc.
RVNC
| $16.8M | ﹤0.01% |
1,214,318
-17,512
| -1% | -$270K |
|
|
ABMD
1689
DELISTED
Abiomed Inc
ABMD
| $16.8M | ﹤0.01% |
67,717
+31,522
| +87% | +$8.51M |
|
|
BLU
1690
DELISTED
BELLUS Health Inc.
BLU
| $16.7M | ﹤0.01% |
1,810,083
+1,712,749
| +1,760% | +$14M |
|
|
OMGA
1691
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $16.7M | ﹤0.01% |
4,385,303
-273,203
| -6% | -$1.02M |
|
|
CCMP
1692
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $16.6M | ﹤0.01% |
94,956
-303
| -0.3% | -$53.7K |
|
1693
Enanta Pharmaceuticals
ENTA
$400M
| $16.6M | ﹤0.01% |
350,333
+108,161
| +45% | +$5.87M |
|
1694
Healthcare Services Group
HCSG
$1.53B
| $16.6M | ﹤0.01% |
950,882
-12,617
| -1% | -$218K |
|
1695
AptarGroup
ATR
$8.61B
| $16.5M | ﹤0.01% |
160,058
-7,265
| -4% | -$792K |
|
1696
Vivid Seats
SEAT
$85.4M
| $16.5M | ﹤0.01% |
110,324
+68,034
| +161% | +$12.3M |
|
1697
Teradata
TDC
$2.55B
| $16.5M | ﹤0.01% |
445,007
+141,064
| +46% | +$5.63M |
|
|
PARA
1698
DELISTED
Paramount Global Class B
PARA
| $16.4M | ﹤0.01% |
665,395
-100,303
| -13% | -$3.06M |
|
|
INBX
1699
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $16.4M | ﹤0.01% |
1,444,642
-1,219
| -0.1% | -$17.9K |
|
1700
G-III Apparel Group
GIII
$1.5B
| $16.3M | ﹤0.01% |
804,153
-1,559,546
| -66% | -$39.4M |
|
Similar funds
Fidelity Investments's Q2 2022 Portfolio in Review
As of Q2 2022, Fidelity Investments held 5,788 positions worth $1T, down 20% from $1.25T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Fidelity Investments's Q2 2022 filing shows 336 new, 2,113 increased, 2,349 reduced and 424 closed positions. Its largest new stake was Aspen Technology Inc: 2,126,791 shares worth $391M. The largest sale was Alphabet (Google) Class A, an estimated $2.73B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q2 2022 buy was Aspen Technology Inc: 2,126,791 shares worth $391M.
- Fidelity Investments added most to iShares National Muni Bond ETF in Q2 2022, an estimated $1.61B increase.
- Fidelity Investments's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $2.73B.
- Fidelity Investments fully exited Anaplan, Inc. in Q2 2022, selling an estimated $478M.
- Fidelity Investments's ten largest holdings make up 26% of its $1T portfolio in Q2 2022.
- Fidelity Investments opened 336 new positions and closed 424 in Q2 2022.
- Fidelity Investments's portfolio value fell 20% quarter-over-quarter to $1T.
Based on Fidelity Investments's 13F filing for Q2 2022, filed 12 Aug 2022.